Skip to content

PHARMEINSA

Active Private limited companyfounded 2022active for 4 yearsAachener Strasse 3, 4780 Saint-VithKBO/BCE: BE 0787.352.463

Timeline

9 events since 2022

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed PDFfull format · 136 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0787352463
Annual accounts 2024 filed PDFfull format · 133 days before the deadline
2024
Highest result from 2022 to 2025 net €184,325 ▲4.6% The operating result of €242,935 and the net result of €184,325 are both a record.
Annual accounts 2023 filed PDFmicro format · 118 days before the deadline
2023
Equity above €200,000 equity €286,528 ▲160% With a profit in every financial year since 2022, equity grows to €286,528.
Annual accounts 2022 filed PDFmicro format · 109 days before the deadline
2022
IncorporationFounding capital of €5,000, 100 shares · Founded by (comparante) · appointed as director · published on 20-06-20226 points ▸
  • Founded by
  • The founding capital is €5,000, divided into 100 shares
  • holds all the shares
  • The registered office is at Aachener Straße 3, 4780 Sankt Vith
  • The board has one director
  • appointed as director, not named in the articles
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

First establishment Aachener Strasse 3, Saint-Vith

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PHARMEINSA was incorporated on 16 June 2022 as a private limited company by one private individual, with a starting capital of €5,000.12 Since 2022, has served as director.3 Total assets rose from €252,610 in 2022 to €757,173 in 2025 and headcount from 1 to 1 full-time equivalents.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 20-06-2022
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2022 and 2025

Next steps